- Display 15 Products per page
Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections)
Published: January 1, 2009 | Price: $3,500.00 – $7,000.00
A nosocomial, or hospital-acquired, infection is a new infection that is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, This type of infection is also known as a hospital-acquired infection (or more generically healthcare-associated infections). Marketing planners in the pharmaceutical or diagnostic industries should have an understanding of the market impact of nosocomial infections, as it will be an important consideration in these markets into the near future. This report. Hospital Acquired...
Novel Autism Diagnostics
Published: February 5, 2016 | Price: $2,000.00 – $4,000.00
Novel Autism Diagnostics Novel Autism Diagnostics reviews selected autism test innovations, summarizing many of the current approaches to autism diagnostics, which include molecular testing, pre-disposition screening, targeted sequencing-based testing, next-generation sequencing with modeling, genetic risk assessment / testing, cloud platform approaches, microarrays, end-to-end sequencing, gene variants, and blood-based genetic testing. The report looks at the companies behind these testing approaches as well. Asuragen, Google Genomics, Illumina, and LabCorp are among the companies discussed within the report’s competitive analysis.
Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications
Published: January 1, 2005 | Price: $3,500.00 – $7,000.00
The concept of nucleic acid-based therapeutics is not a new one. For a long time it has been thought that molecules similar to those that make up our genetic structure would make effective therapeutics. It is an idea whose time has come. There are six types of nucleic acid-based therapeutics that have been proposed. Some have made it to market, others are still in development, and some have been put on the back burner due to technical difficulties. The six...
Obesity – The Worldwide Market for Pharmaceutical and Surgical Treatment
Published: June 1, 2006 | Price: $995.00 – $7,000.00
Despite troublesome safety problems with past entrants into this market, the veritable epidemic of overweight and obesity continues to make this sector an extremely attractive target for pharmaceutical developers. This new title provides a considered view of the market for medical interventions in the battle against obesity, including U.S. and worldwide market size and growth forecasts, competitive market share and extensive pharmaceutical pipeline information. The report discusses both prescription and OTC drug markets and surgical interventions. Market size and growth...
Obesity, Weight Loss and Diet Management Markets (Pharmaceutical, Surgical and Dietary Approaches)
Published: December 1, 2009 | Price: $995.00 – $4,200.00
Weight loss and diet management is a challenge for millions of people around the world. Globally, more than 1 billion people are above an ideal weight. The affects weight has on life-threatening or life-altering disease are devastating. Diseases such as diabetes, heart disease, and cancer all have links to being overweight or obese. Increasing education efforts, accessible weight management plans and foods, and a growing desire to be physically desirable have fueled this market in more recent years. More than...
OEM Contract Manufacturing in Medical Devices, Vol I: Materials Processing
Published: August 1, 2007 | Price: $2,400.00 – $6,990.00
Abundant opportunities are available for manufacturing companies who enter the outsourcing medical device manufacturing market; but the market is competitive and information has been hard to obtain. Original equipment manufacturers are finding new opportunities with managers located at the corporate headquarters or main manufacturing/assembly operations continually reviewing manufacturing costs and looking to outsourcing for cost efficiency. Kalorama's OEM Contract Manufacturing in Medical Devices Series presents a total study of market for outsourcing in medical devices. It features an exhaustive three-way...
OEM Contract Manufacturing in Medical Devices, Vol II – Electronics and Advanced Systems
Published: October 1, 2007 | Price: $1,995.00 – $6,990.00
Abundant opportunities are available for electronics and advanced systems companies who enter the outsourcing medical device manufacturing market; but the market is competitive and information has been hard to obtain. Contract Manufacturers(CMs) are finding opportunities with managers located at the corporate headquarters or main manufacturing/assembly operations as they take a hard look at costs and seek outsourcing for cost efficiency. Kalorama's OEM Contract Manufacturing in Medical Devices Series presents a total study of market for outsourcing in medical devices. It...
OEM Contract Manufacturing in Medical Devices, World Market, Vol III – Finished Clinical Products and Systems
Published: November 1, 2007 | Price: $1,995.00 – $6,990.00
Contract Manufacturers are finding opportunities with managers located at OEM corporate headquarters or main manufacturing/assembly operations as they take a hard look at costs and seek outsourcing for cost efficiency. Once satisfied with outsourcing only a small part of operations, OEM companies are now looking to CMs for finished products and finished computer systems. The highly skilled firms who compete in this area meet the challenges of overburdened OEM device companies demanding a ready-to-launch product. Kalorama's OEM Contract Manufacturing in...
Offshoring Clinical Trials (The Market for Clinical Trials in India, China, Mexico, Brazil, Russia and Israel.)
Published: November 1, 2007 | Price: $1,500.00 – $7,000.00
Offshoring of clinical trials is increasing as companies in the U.S. are finding challenges in clinical trial research ranging from cost, patient recruitment, patient compliance during participation, qualified professionals, new clinical trial patients, and other problems. This provides an opportunity for BRIC countries and other developing regions to grab a piece of the clinical trial market. Countries such as India and China have a vast population who are interested in taking part in clinical trial research, and these regions can...
Organ Transplant Immunosuppressive Markets
Published: January 1, 2008 | Price: $995.00 – $1,990.00
Improved surgical techniques and organ preservation, understanding of immunologic barriers, and the development of newer and more potent immunosuppressives have combined to improve survival of transplant patients and grafts. Rejection remains the major barrier to long-term graft survival in patients, organ transplantation therapy is highly dependent on the success of immunosuppressants to suppress the recipient’s immune responses to the foreign organ. Most transplant patients require lifelong immunosuppressive therapy to prevent rejection, except when human leukocyte antigen (HLA)-identical transplants are used....
Orthopedic Biomaterials, The World Market, 2nd Edition
Published: September 1, 2007 | Price: $1,995.00 – $7,000.00
Orthopedic biomaterial products, which can be organic or synthetic in nature, are implanted into or near a bone fracture to facilitate healing or to compensate for a lack or loss of bone tissue. Biomaterials used in orthopedic surgery include autografts, allografts, xenografts, ceramics, polymers, bone growth factors and synovial fluid substitutes. Among the prominent applications for orthopedic biomaterials are surface coatings for hip prostheses, bone cements, bone defect fillers, and fracture fixation plates. Technological advancement and an aging, active population...
OTC Women’s Health: A Supplement to Women’s Health, 3rd Edition
Published: August 1, 2003 | Price: $1,496.00 – $2,992.00
The OTC women’s health market encompasses a wide variety of products that have been determined safe and effective as over-the-counter products. The market is driven by several factors including increasing number of baby boomers entering old age, increasing incidences of diseases; product demand; and several others. In response to many inquiries from readers of Kalorama Information’s March 2003 publication Women’s Health: Worldwide Prescription Drug Markets, 3rd Edition, we embarked on a supplemental study that goes beyond the prescription market to...
Out of Pocket Healthcare Spending 2013
Published: June 18, 2013 | Price: $1,500.00 – $3,000.00
This report, Out of Pocket Healthcare 2013, is Kalorama's latest estimates for the amount spent by consumers on their own (through cash payments, credit cards, FSAs and finance programs) for healthcare services. The out-of -pocket market for the following areas are included: Doctors Pharmaceuticals Hospitals ER Vision Dental Elective Procedures The report estimates the amount spent in cash/checks and the amount financed. As part of the report, spending for the following healthcare costs are provided for years 2008-2016: Premiums Co...
Out-of-Pocket Healthcare Expenditures in the United States
Published: April 2, 2019 | Price: $4,000.00 – $8,000.00
A variety of demographic, business, and government trends are contributing to rising out-of-pocket (OOP) healthcare expenses in the United States. Out-of-Pocket Healthcare Expenditures in the United States examines these trends in detail, focusing on the financial aspects of OOP spending growth and quantifying the growth of OOP spending with forecasts of total expenditures and specialized healthcare financing. Total Expenditures The report examines past, current, and future levels of U.S. out-of-pocket healthcare expenditures both in total and as specific sub-groups (by type, by...
Out-of-Pocket Healthcare Expenditures in the United States
Published: April 17, 2017 | Price: $796.00 – $1,592.00
Out-of-Pocket Healthcare Expenditures in the United States Out-of-Pocket Healthcare Expenditures in the United States examines the average person’s out-of-pocket medical costs, including: Distribution of Out-of-Pocket Spending for the Average Person, 2016, 2021 Consumer Out-of-Pocket Expenditures per Worker, 2011–2021 Consumer Out-of-Pocket Expenditures by Type, 2011–2021 Proportion of Consumer Out-of-Pocket Spending by Type of Healthcare Expenditure, 2011, 2016, 2021 Average Share Paid Out-of-Pocket by U.S. Residents with Healthcare Spending by Percentile of Total Health Spending and Type of Service, 2016 Average Share...